We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.66%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$80.1B
AUM Growth
+$9.71B
(+14%)
Cap. Flow
+$17.3B
Cap. Flow
% of AUM
21.56%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
1,430
New
62
Increased
858
Reduced
440
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$13B |
| 2 |
NVIDIA
NVDA
|
+$468M |
| 3 |
ASML
ASML
|
+$424M |
| 4 |
Applied Materials
AMAT
|
+$310M |
| 5 |
Qualcomm
QCOM
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinross Gold
KGC
|
+$444M |
| 2 |
Tyler Technologies
TYL
|
+$256M |
| 3 |
C.H. Robinson
CHRW
|
+$251M |
| 4 |
Philip Morris
PM
|
+$245M |
| 5 |
RTX Corp
RTX
|
+$234M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.76% |
| 2 | Materials | 26.89% |
| 3 | Healthcare | 7.04% |
| 4 | Industrials | 6.5% |
| 5 | Financials | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Brookfield Renewable
BEPC
$6.34B
| $3.96M | ﹤0.01% |
115,457
-26,405
| -19% | -$766K |
|
727
Commault Systems
CVLT
$5.47B
| $3.94M | ﹤0.01% |
29,812
+8,519
| +40% | +$1.2M |
|
728
Cboe Global Markets
CBOE
$31.1B
| $3.93M | ﹤0.01% |
18,421
+1,827
| +11% | +$359K |
|
729
Gaming and Leisure Properties
GLPI
$12.7B
| $3.92M | ﹤0.01% |
77,046
-5,771
| -7% | -$286K |
|
730
Arrow Electronics
ARW
$11.6B
| $3.92M | ﹤0.01% |
29,576
+8,450
| +40% | +$1.07M |
|
731
Exponent
EXPO
$3.31B
| $3.88M | ﹤0.01% |
36,194
+10,342
| +40% | +$1.08M |
|
732
Progressive
PGR
$122B
| $3.88M | ﹤0.01% |
15,672
-861
| -5% | -$200K |
|
733
Celestica
CLS
$42.7B
| $3.87M | ﹤0.01% |
67,266
+19,221
| +40% | +$993K |
|
734
Cognex
CGNX
$11.2B
| $3.86M | ﹤0.01% |
99,529
+28,161
| +39% | +$1.2M |
|
735
Louisiana-Pacific
LPX
$5.15B
| $3.85M | ﹤0.01% |
38,468
+9,735
| +34% | +$918K |
|
|
ADAM
736
Adamas Trust
ADAM
$848M
| $3.85M | ﹤0.01% |
735,576
-50,697
| -6% | -$326K |
|
737
Coca-Cola Consolidated
COKE
$12B
| $3.84M | ﹤0.01% |
30,140
+8,610
| +40% | +$1.05M |
|
738
Chubb
CB
$134B
| $3.84M | ﹤0.01% |
13,010
+359
| +3% | +$98.4K |
|
739
Canadian Natural Resources
CNQ
$96.7B
| $3.83M | ﹤0.01% |
108,992
-1,285
| -1% | -$44.7K |
|
740
Nice
NICE
$6.05B
| $3.82M | ﹤0.01% |
21,766
+337
| +2% | +$57.9K |
|
741
Invesco Quality Municipal Securities
IQI
$521M
| $3.82M | ﹤0.01% |
380,611
-7,021
| -2% | -$71.5K |
|
742
West Pharmaceutical
WST
$24.5B
| $3.82M | ﹤0.01% |
13,326
-722
| -5% | -$221K |
|
743
PureCycle Technologies
PCT
$1.45B
| $3.81M | ﹤0.01% |
345,311
-181,918
| -35% | -$1.22M |
|
744
Cytokinetics
CYTK
$10.4B
| $3.8M | ﹤0.01% |
71,691
+12,565
| +21% | +$700K |
|
|
BLE
745
DELISTED
BlackRock Municipal Income Trust II
BLE
| $3.8M | ﹤0.01% |
347,783
-11,562
| -3% | -$128K |
|
746
United Therapeutics
UTHR
$21.9B
| $3.79M | ﹤0.01% |
10,756
-138
| -1% | -$46.6K |
|
747
Brixmor Property Group
BRX
$9.57B
| $3.78M | ﹤0.01% |
135,479
+14,715
| +12% | +$380K |
|
748
Rivian
RIVN
$22.8B
| $3.78M | ﹤0.01% |
372,093
+88,047
| +31% | +$1.26M |
|
749
ATI
ATI
$26.4B
| $3.77M | ﹤0.01% |
59,942
-17,741
| -23% | -$1.1M |
|
750
monday.com
MNDY
$3.76B
| $3.74M | ﹤0.01% |
13,244
+205
| +2% | +$50.7K |
|
Similar funds
VanEck Associates's Q3 2024 Portfolio in Review
As of Q3 2024, VanEck Associates held 1,430 positions worth $80.1B, up 14% from $70.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
VanEck Associates deployed $17.3B of net new capital in Q3 2024, opening 62 new positions and adding to 858 existing holdings. Its largest new stake was GE HealthCare: 2,335,235 shares worth $209M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Materials and Healthcare.
On the sell side, the largest reduction was Kinross Gold, an estimated $444M trimmed.
- VanEck Associates's largest Q3 2024 buy was GE HealthCare: 2,335,235 shares worth $209M.
- VanEck Associates added most to Lam Research in Q3 2024, an estimated $13B increase.
- VanEck Associates's biggest Q3 2024 reduction was Kinross Gold, cutting an estimated $444M.
- VanEck Associates fully exited RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock in Q3 2024, selling an estimated $22.4M.
- VanEck Associates's ten largest holdings make up 29% of its $80.1B portfolio in Q3 2024.
- VanEck Associates opened 62 new positions and closed 53 in Q3 2024.
- VanEck Associates's portfolio value rose 14% quarter-over-quarter to $80.1B.
Based on VanEck Associates's 13F filing for Q3 2024, filed 29 Oct 2024.